Paper36969569
Connexin 45 is a novel suppressor of melanoma metastasis.
Saito M and 6 others. Cytotechnology, 2023. Cited by 5 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Connexin 45 is a novel suppressor of melanoma metastasis. Papers, record 36969569. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36969569
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35,022,385 | Connexin 43 confers chemoresistance through activating PI3K. | Oncogenesis | 2022 | https://conductscience.org/library/papers/35022385 | PubMed |
| 2 | 30,814,684 | Connexins in cancer: bridging the gap to the clinic. | Oncogene | 2019 | https://conductscience.org/library/papers/30814684 | PubMed |
| 3 | 24,492,000 | EGF induces efficient Cx43 gap junction endocytosis in mouse embryonic stem cell colonies via phosphorylation of Ser262, Ser279/282, and Ser368. | FEBS Lett | 2014 | https://conductscience.org/library/papers/24492000 | PubMed |
| 4 | 31,787,758 | The many substrates and functions of NEDD4-1. | Cell Death Dis | 2019 | https://conductscience.org/library/papers/31787758 | PubMed |
| 5 | 35,693,635 | Recent advances in connexin gap junction biology. | Fac Rev | 2022 | https://conductscience.org/library/papers/35693635 | PubMed |
| 6 | 11,815,665 | Biophysical properties of connexin-45 gap junction hemichannels studied in vertebrate cells. | J Gen Physiol | 2002 | https://conductscience.org/library/papers/11815665 | PubMed |
| 7 | 26,135,897 | Overexpression of connexin 43 reduces melanoma proliferative and metastatic capacity. | Br J Cancer | 2015 | https://conductscience.org/library/papers/26135897 | PubMed |
| 8 | 23,455,769 | Proteins and mechanisms regulating gap-junction assembly, internalization, and degradation. | Physiology (Bethesda) | 2013 | https://conductscience.org/library/papers/23455769 | PubMed |
| 9 | 26,524,530 | Tumour exosome integrins determine organotropic metastasis. | Nature | 2015 | https://conductscience.org/library/papers/26524530 | PubMed |
| 10 | 24,155,720 | Managing the complexity of communication: regulation of gap junctions by post-translational modification. | Front Pharmacol | 2013 | https://conductscience.org/library/papers/24155720 | PubMed |
| 11 | 29,422,613 | Cx26 drives self-renewal in triple-negative breast cancer via interaction with NANOG and focal adhesion kinase. | Nat Commun | 2018 | https://conductscience.org/library/papers/29422613 | PubMed |
| 12 | 26,439,696 | Cx26 knockout predisposes the mammary gland to primary mammary tumors in a DMBA-induced mouse model of breast cancer. | Oncotarget | 2015 | https://conductscience.org/library/papers/26439696 | PubMed |
| 13 | 33,603,164 | Cx43 phosphorylation sites regulate pancreatic cancer metastasis. | Oncogene | 2021 | https://conductscience.org/library/papers/33603164 | PubMed |
| 14 | 35,456,480 | Connexin Expression in Pituitary Adenomas and the Effects of Overexpression of Connexin 43 in Pituitary Tumor Cell Lines. | Genes (Basel) | 2022 | https://conductscience.org/library/papers/35456480 | PubMed |
| 15 | 26,251,520 | Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer. | J Clin Pathol | 2015 | https://conductscience.org/library/papers/26251520 | PubMed |
| 16 | 4,512,654 | Selection of successive tumour lines for metastasis. | Nat New Biol | 1973 | https://conductscience.org/library/papers/4512654 | PubMed |
| 17 | 35,682,601 | The Expression of Connexin 37, 40, 43, 45 and Pannexin 1 in the Early Human Retina and Choroid Development and Tumorigenesis. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35682601 | PubMed |
| 18 | 23,800,357 | Connexin-43 can delay early recurrence and metastasis in patients with hepatitis B-related hepatocellular carcinoma and low serum alpha-fetoprotein after radical hepatectomy. | BMC Cancer | 2013 | https://conductscience.org/library/papers/23800357 | PubMed |
| 19 | 24,788,723 | Membrane connexin 43 acts as an independent prognostic marker in oral squamous cell carcinoma. | Int J Oncol | 2014 | https://conductscience.org/library/papers/24788723 | PubMed |
| 20 | 21,866,551 | Connexin43 acts as a colorectal cancer tumor suppressor and predicts disease outcome. | Int J Cancer | 2012 | https://conductscience.org/library/papers/21866551 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,643,577 | IsoformSwitchAnalyzeR v2: analysis of functional isoform changes in long-read and single-cell sequencing data. | NAR Genom Bioinform | 2026 | https://conductscience.org/library/papers/42643577 | PubMed |
| 41,063,451 | Novel Strategy for Acquiring Metabolically-Tagged Nascent Extracellular Vesicles: Implications for Identifying Surface Protein Markers of Extracellular Vesicles From Neuroblastoma Cells Cultured With Native Serum. | J Extracell Vesicles | 2025 | https://conductscience.org/library/papers/41063451 | PubMed |
| 40,615,399 | Cx43 enhances response to BRAF/MEK inhibitors by reducing DNA repair capacity. | Nat Commun | 2025 | https://conductscience.org/library/papers/40615399 | PubMed |
| 39,360,264 | Discovery of GJC1 as a prognostic biomarker in glioma cells: insights into its cell-cycle relationship and differential expression in non-neuronal cells. | Front Cell Neurosci | 2024 | https://conductscience.org/library/papers/39360264 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36969569
GET https://conductscience.org/api/papers/v1/36969569/references?page=2